Nantahala Capital Management, LLC Dyne Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.06 - $29.18 $2.71 Million - $6.06 Million	-207,533 Reduced 32.29%	435,256 $12.4 Million
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $267,282 - $550,715	-40,375 Reduced 5.91%	642,789 $8.55 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $774,000 - $1.1 Million	90,000 Added 15.17%	683,164 $6.12 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $3.53 Million - $5.92 Million	414,263 Added 231.56%	593,164 $6.67 Million
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $1.95 Million - $2.68 Million	178,901 New	178,901 $2.06 Million

201

106M

82.7K

24.8K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.71B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.